The peripheral angioplasty market size is projected to be worth US$ 3.4 billion in 2023. The market is likely to surpass US$ 7.2 billion by 2033 at a CAGR of 7.7% during the forecast period. A minimally invasive treatment called peripheral angioplasty, sometimes referred to as peripheral arterial angioplasty or percutaneous transluminal angioplasty (PTA), is used to treat peripheral artery disease (PAD). It is a procedure used in medicine to unblock arteries in the peripheral vascular system that are clogged or narrowed, especially in the lower extremities (legs, feet, and ankles).
A small, flexible catheter with a deflated balloon connected to its tip is introduced into the troubled artery during peripheral angioplasty. Using imaging methods like fluoroscopy or angiography, the catheter is directed to the location of the obstruction or constriction. Once in place, the balloon is inflated to widen the arterial lumen and compress plaque or fatty deposits against the artery walls, allowing normal blood flow to resume. In rare circumstances, a stent (a tiny
Other Drivers Propelling the Demand for Peripheral Angioplasty include:
Challenges for Companies /Manufacturers in the Peripheral Angioplasty Market:
Opportunities in the Peripheral Angioplasty Industry:
Latest Trends in the Peripheral Angioplasty Market:
| Attributes | Details |
|---|---|
| Peripheral Angioplasty Market Size (2023) | US$ 3.4 billion |
| Peripheral Angioplasty Market Projected Size (2033) | US$ 7.2 billion |
| Value CAGR (2023 to 2033) | 7.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global peripheral angioplasty market experienced a CAGR of 5.4%, reaching a market size of US$ 3.4 billion in 2023.
From 2012 to 2022, Over the years, there has been consistent expansion in the peripheral angioplasty market. The market has grown dramatically as a result of improvements in medical device technology, rising awareness of peripheral artery disease (PAD), and an ageing population. Typically, the historic period includes data from the previous ten years. During this time, the market expanded significantly as a result of the increased incidence of PAD and the rising popularity of minimally invasive procedures.
Future Forecast for Peripheral Angioplasty Industry:
Looking ahead, the global peripheral angioplasty industry is expected to rise at a CAGR of 7.7% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 7.2 billion by 2033.
The market for peripheral angioplasty is expected to continue growing in the years to come, according to the forecast. The market is anticipated to expand as a result of factors such the ageing population, rising PAD prevalence, device technology developments, and growing public awareness of the advantages of minimally invasive procedures.
| Country | The United States |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 2.3 billion |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The peripheral angioplasty industry in the United States is expected to reach a market size of US$ 2.3 billion by 2033, expanding at a CAGR of 6.8%. Early diagnosis and treatments have been made possible by greater awareness of peripheral artery disease and the symptoms it is linked with. More patients who need peripheral angioplasty treatments have been found thanks to screening programs and public health initiatives that attempt to inform people about the dangers and symptoms of PAD. The management of PAD and the expansion of the market depend on prompt diagnosis and treatment.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 229.3 million |
| CAGR % 2023 to End of Forecast (2033) | 4.2% |
The peripheral angioplasty industry in the United Kingdom is expected to reach a market value of US$ 229.3 million, expanding at a CAGR of 4.2% during the forecast period. The presence of the National Health Service (NHS) in the UK plays a significant role in the growth of the peripheral angioplasty market. The NHS provides comprehensive healthcare coverage, including peripheral angioplasty procedures, making them accessible to a large population. The support of the NHS in terms of infrastructure, reimbursement, and access to healthcare services contributes to the growth of the market.
| Country | China |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 732.1 million |
| CAGR % 2023 to End of Forecast (2033) | 13.0% |
The peripheral angioplasty industry in China is anticipated to reach a market size of US$ 732.1 million, moving at a CAGR of 13.0% during the forecast period. China's rising healthcare expenditure plays a vital role in the growth of the peripheral angioplasty market. The government's commitment to expanding healthcare coverage, improving the quality of care, and addressing the burden of chronic diseases supports the demand for peripheral angioplasty procedures. Increased healthcare expenditure ensures better access to medical services and devices, including peripheral angioplasty devices.
| Country | Japan |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 448.8 million |
| CAGR % 2023 to End of Forecast (2033) | 9.0% |
The peripheral angioplasty industry in Japan is estimated to reach a market size of US$ 448.8 million by 2033, thriving at a CAGR of 9.0%. The Japanese healthcare system provides universal health coverage through the public health insurance system. This coverage includes reimbursement for peripheral angioplasty procedures, making them accessible to a wide population. Favorable reimbursement policies ensure the availability and affordability of peripheral angioplasty devices, driving market growth.
| Country | South Korea |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 143.7 million |
| CAGR % 2023 to End of Forecast (2033) | 8.7% |
The peripheral angioplasty industry in South Korea is expected to reach a market size of US$ 143.7 million, expanding at a CAGR of 8.7% during the forecast period. In South Korea, partnerships between medical device producers, healthcare providers, and research organizations foster innovation and commercial expansion. Clinical trials, knowledge exchange, and research and development are all made possible via partnerships. Collaborations help to enhance peripheral angioplasty technologies and encourage the use of these tools in clinical settings.
Principal Consultant
The balloon catheters are expected to dominate the peripheral angioplasty industry with a CAGR of 5.2% from 2023 to 2033. Balloon catheters are a fundamental component of peripheral angioplasty procedures. They are used to dilate narrowed or blocked blood vessels in the peripheral arteries, restoring blood flow to the affected area. The effectiveness of balloon catheters in achieving vessel dilation makes them an indispensable tool in the field of peripheral angioplasty.
The hospitals segments are expected to dominate the peripheral angioplasty industry with a CAGR of 6.3% from 2023 to 2033. Hospitals provide the necessary infrastructure and resources to perform peripheral angioplasty procedures. They house specialized catheterization laboratories equipped with advanced imaging technologies, such as fluoroscopy and angiography, that aid in the precise visualization and guidance during the procedure. Access to these advanced treatment facilities in hospitals ensures the availability of peripheral angioplasty services to patients.
The peripheral angioplasty sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic partnerships and alliances with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.
In emerging economies like China and India, the market for peripheral angioplasty is growing quickly. To boost their presence in these regions, major companies are expanding their distribution networks and setting up local manufacturing units.
Mergers and acquisitions are frequently used by key players in the peripheral angioplasty business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Peripheral Angioplasty Market:
The hospital sector holds high revenue potential.
The United States, China and the United Kingdom dominate the global market.
The market is forecast to register a CAGR of 7.7% through 2033.
The market registered a CAGR of 5.4% from 2018 to 2022.
The high quality care to enhance patients outcomes are the current market trends.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Number of Procedures 4.3. Reimbursement Scenario 4.4. Regulatory Landscape 4.5. PESTEL Analysis 4.6. Porter’s Analysis 4.7. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Diagnosis Rate (%) 5.2.3. Increasing Prevalence of Peripheral Artery Disease 5.2.4. Favourable Government Regulations 5.2.5. Rising Demand for Bypass Surgeries 5.2.6. Cost Per Stent 5.2.7. Technological Advancements in Catheters 5.2.8. Frequency of Product Approvals 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2012 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 9.3.1. Balloon Catheters 9.3.2. Stents 9.3.3. Guidewires 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 10.3.1. Hospitals 10.3.2. Ambulatory Surgical Centers 10.3.3. Cardiac Catheterization Centres 10.4. Market Attractiveness Analysis By End User 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2022 11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. South Asia 11.3.5. East Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (Middle East & Africa) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. USA 12.3.1.2. Canada 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Country Level Analysis & Forecast 12.5.1. USA Market Analysis 12.5.1.1. Introduction 12.5.1.2. Market Analysis and Forecast by Market Taxonomy 12.5.1.2.1. By Product 12.5.1.2.2. By End User 12.5.2. Canada Market Analysis 12.5.2.1. Introduction 12.5.2.2. Market Analysis and Forecast by Market Taxonomy 12.5.2.2.1. By Product 12.5.2.2.2. By End User 12.6. Market Trends 12.7. Key Market Participants - Intensity Mapping 12.8. Drivers and Restraints - Impact Analysis 13. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Country Level Analysis & Forecast 13.5.1. Brazil Market Analysis 13.5.1.1. Introduction 13.5.1.2. Market Analysis and Forecast by Market Taxonomy 13.5.1.2.1. By Product 13.5.1.2.2. By End User 13.5.2. Mexico Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Product 13.5.2.2.2. By End User 13.5.3. Argentina Market Analysis 13.5.3.1. Introduction 13.5.3.2. Market Analysis and Forecast by Market Taxonomy 13.5.3.2.1. By Product 13.5.3.2.2. By End User 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. France 14.3.1.3. Italy 14.3.1.4. UK 14.3.1.5. Spain 14.3.1.6. Russia 14.3.1.7. BENELUX 14.3.1.8. Rest of Europe 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Material 14.4.4. By End User 14.5. Country Level Analysis & Forecast 14.5.1. Germany Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By End User 14.5.2. France Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By End User 14.5.3. Italy Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Product 14.5.3.2.2. By End User 14.5.4. UK Market Analysis 14.5.4.1. Introduction 14.5.4.2. Market Analysis and Forecast by Market Taxonomy 14.5.4.2.1. By Product 14.5.4.2.2. By End User 14.5.5. Spain Market Analysis 14.5.5.1. Introduction 14.5.5.2. Market Analysis and Forecast by Market Taxonomy 14.5.5.2.1. By Product 14.5.5.2.2. By End User 14.5.6. Russia Market Analysis 14.5.6.1. Introduction 14.5.6.2. Market Analysis and Forecast by Market Taxonomy 14.5.6.2.1. By Product 14.5.6.2.2. By End User 14.5.7. BENELUX Market Analysis 14.5.7.1. Introduction 14.5.7.2. Market Analysis and Forecast by Market Taxonomy 14.5.7.2.1. By Product 14.5.7.2.2. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Country Level Analysis & Forecast 15.5.1. India Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By End User 15.5.2. Thailand Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By End User 15.5.3. Indonesia Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By End User 15.5.4. Malaysia Market Analysis 15.5.4.1. Introduction 15.5.4.2. Market Analysis and Forecast by Market Taxonomy 15.5.4.2.1. By Product 15.5.4.2.2. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Country Level Analysis & Forecast 16.5.1. China Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By End User 16.5.2. Japan Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By End User 16.5.3. South Korea Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By End User 17.5. Country Level Analysis & Forecast 17.5.1. Australia Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By End User 17.5.2. New Zealand Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Türkiye 18.3.1.3. Northern Africa 18.3.1.4. South Africa 18.3.1.5. Rest of Middle East and Africa 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By End User 18.5. Country Level Analysis & Forecast 18.5.1. GCC Countries Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By End User 18.5.2. Türkiye Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By End User 18.5.3. Northern Africa Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By End User 18.5.4. South Africa Market Analysis 18.5.4.1. Introduction 18.5.4.2. Market Analysis and Forecast by Market Taxonomy 18.5.4.2.1. By Product 18.5.4.2.2. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Share Analysis of Top Players 19.3. Market Presence Analysis 20. Competition Analysis 20.1. Competition Dashboard 20.2. Branding and Promotional Strategies, By Key Players 20.3. Key Development Analysis 20.4. Competition Deep Dive 20.4.1. Boston Scientific Corporation 20.4.1.1. Overview 20.4.1.2. Product Portfolio 20.4.1.3. Key Financials 20.4.1.4. Sales Footprint 20.4.1.5. SWOT Analysis 20.4.1.6. Strategy Overview 20.4.1.6.1. Marketing Strategy 20.4.1.6.2. Product Strategy 20.4.1.6.3. Channel Strategy 20.4.2. Medtronic 20.4.2.1. Overview 20.4.2.2. Product Portfolio 20.4.2.3. Key Financials 20.4.2.4. Sales Footprint 20.4.2.5. SWOT Analysis 20.4.2.6. Strategy Overview 20.4.2.6.1. Marketing Strategy 20.4.2.6.2. Product Strategy 20.4.2.6.3. Channel Strategy 20.4.3. Abbott Laboratories 20.4.3.1. Overview 20.4.3.2. Product Portfolio 20.4.3.3. Key Financials 20.4.3.4. Sales Footprint 20.4.3.5. SWOT Analysis 20.4.3.6. Strategy Overview 20.4.3.6.1. Marketing Strategy 20.4.3.6.2. Product Strategy 20.4.3.6.3. Channel Strategy 20.4.4. Terumo Corporation 20.4.4.1. Overview 20.4.4.2. Product Portfolio 20.4.4.3. Key Financials 20.4.4.4. Sales Footprint 20.4.4.5. SWOT Analysis 20.4.4.6. Strategy Overview 20.4.4.6.1. Marketing Strategy 20.4.4.6.2. Product Strategy 20.4.4.6.3. Channel Strategy 20.4.5. Johnson & Johnson 20.4.5.1. Overview 20.4.5.2. Product Portfolio 20.4.5.3. Key Financials 20.4.5.4. Sales Footprint 20.4.5.5. SWOT Analysis 20.4.5.6. Strategy Overview 20.4.5.6.1. Marketing Strategy 20.4.5.6.2. Product Strategy 20.4.5.6.3. Channel Strategy 20.4.6. Cook Medical 20.4.6.1. Overview 20.4.6.2. Product Portfolio 20.4.6.3. Key Financials 20.4.6.4. Sales Footprint 20.4.6.5. SWOT Analysis 20.4.6.6. Strategy Overview 20.4.6.6.1. Marketing Strategy 20.4.6.6.2. Product Strategy 20.4.6.6.3. Channel Strategy 20.4.7. B. Braun Melsungen AG 20.4.7.1. Overview 20.4.7.2. Product Portfolio 20.4.7.3. Key Financials 20.4.7.4. Sales Footprint 20.4.7.5. SWOT Analysis 20.4.7.6. Strategy Overview 20.4.7.6.1. Marketing Strategy 20.4.7.6.2. Product Strategy 20.4.7.6.3. Channel Strategy 20.4.8. Edwards Lifesciences Corporation 20.4.8.1. Overview 20.4.8.2. Product Portfolio 20.4.8.3. Key Financials 20.4.8.4. Sales Footprint 20.4.8.5. SWOT Analysis 20.4.8.6. Strategy Overview 20.4.8.6.1. Marketing Strategy 20.4.8.6.2. Product Strategy 20.4.8.6.3. Channel Strategy 20.4.9. Becton, Dickinson and Company 20.4.9.1. Overview 20.4.9.2. Product Portfolio 20.4.9.3. Key Financials 20.4.9.4. Sales Footprint 20.4.9.5. SWOT Analysis 20.4.9.6. Strategy Overview 20.4.9.6.1. Marketing Strategy 20.4.9.6.2. Product Strategy 20.4.9.6.3. Channel Strategy 20.4.10. MicroPort Scientific Corporation 20.4.10.1. Overview 20.4.10.2. Product Portfolio 20.4.10.3. Key Financials 20.4.10.4. Sales Footprint 20.4.10.5. SWOT Analysis 20.4.10.6. Strategy Overview 20.4.10.6.1. Marketing Strategy 20.4.10.6.2. Product Strategy 20.4.10.6.3. Channel Strategy 20.4.11. Teleflex Incorporated 20.4.11.1. Overview 20.4.11.2. Product Portfolio 20.4.11.3. Key Financials 20.4.11.4. Sales Footprint 20.4.11.5. SWOT Analysis 20.4.11.6. Strategy Overview 20.4.11.6.1. Marketing Strategy 20.4.11.6.2. Product Strategy 20.4.11.6.3. Channel Strategy 20.4.12. W. L. Gore & Associates 20.4.12.1. Overview 20.4.12.2. Product Portfolio 20.4.12.3. Key Financials 20.4.12.4. Sales Footprint 20.4.12.5. SWOT Analysis 20.4.12.6. Strategy Overview 20.4.12.6.1. Marketing Strategy 20.4.12.6.2. Product Strategy 20.4.12.6.3. Channel Strategy 20.4.13. Biotronik SE & Co. KG 20.4.13.1. Overview 20.4.13.2. Product Portfolio 20.4.13.3. Key Financials 20.4.13.4. Sales Footprint 20.4.13.5. SWOT Analysis 20.4.13.6. Strategy Overview 20.4.13.6.1. Marketing Strategy 20.4.13.6.2. Product Strategy 20.4.13.6.3. Channel Strategy 20.4.14. AngioDynamics, Inc. 20.4.14.1. Overview 20.4.14.2. Product Portfolio 20.4.14.3. Key Financials 20.4.14.4. Sales Footprint 20.4.14.5. SWOT Analysis 20.4.14.6. Strategy Overview 20.4.14.6.1. Marketing Strategy 20.4.14.6.2. Product Strategy 20.4.14.6.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Peripheral Angioplasty Market
